Health News
Roche gets boost from FDA in bid to expand uses for Actemra
ZURICH The U.S. Food and Drug Administration has granted breakthrough status to Roche's rheumatoid arthritis medication Actemra for giant cell arteritis, the Swiss drugmaker said, a step which could help it broaden applications for the medicine.
More Headlines
Still unclear which remedies are best for morning sickness
(Reuters Health) - Even though nearly all women experience at least a little nausea or vomiting during pregnancy, there isn’t much solid evidence to suggest the best treatments, a research review concludes.
Canadian college to launch marijuana cultivation course
TORONTO A college in the Atlantic Canadian province of New Brunswick plans to institute a program on marijuana cultivation so that students can be trained to work at local companies that produce the drug, a school official said on Tuesday.
Botox shots little better than nerve stimulation for incontinence
(Reuters Health) - Botox injections may be slightly better at reducing urinary incontinence in some older women than InterStim, an implanted bladder control device, results of a U.S. trial suggest.
Sarepta partners with UK's Summit on Duchenne drugs
Sarepta Therapeutics Inc said it secured the European rights to Summit Therapeutics Plc's experimental Duchenne muscular dystrophy (DMD) drug as it looks to build on its lead in treating the fatal muscle-wasting disease.
Health Watch Graphics
Track and Field - Injuries overview
Based on injury events from 2002-2015 that involved a trip to an emergency room in the United States. Full Article
Sleep apnea by the numbers
Sleep apnea is thought to affect at least 5 percent of men and 3-4 percent of women, but many estimates put that number higher because people with sleep apnea don't tend to realize they have it. Interactive